Navigation Links
Lexicon to Present Clinical Data for Diabetes Drug Candidate, LX4211, at Two Major Healthcare Conferences
Date:6/15/2010

THE WOODLANDS, Texas, June 15 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that it will be presenting clinical data from its Phase 2a clinical trial of LX4211 for patients with type 2 diabetes mellitus at ENDO 2010: The 92nd Annual Meeting and Expo, June 19 – 22, 2010 in San Diego, California and the 70th Scientific Sessions of the American Diabetes Association, June 25 – 29, 2010 in Orlando, Florida.

ENDO 2010: The 92nd Annual Meeting and Expo

David Powell, M.D., Lexicon's senior vice president of metabolism research, will give a presentation at ENDO 2010 titled "LX4211, a Dual SGLT1 and SGLT2 Inhibitor, Shows Rapid and Significant Improvement in Glycemic Control over 4 Weeks in Patients with Type 2 Diabetes Mellitus" on Monday, June 21, 2010 at 11:15 a.m. Pacific Time.  

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology news :

1. Decoding the dictionary: Study suggests lexicon evolved to fit in the brain
2. Heart of Herschel to be presented to media
3. Frontiers in Optics presents scientific advancements
4. Male contraception breakthroughs to be presented, Seattle Sept. 27-28
5. New book presents successful strategies for probing genetic variation
6. NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research
7. Chemical compound present in detergents produce bacteria alterations in agricultural soils
8. New book presents methods to poke and prod individual molecules
9. Present-day species of piranha result from a marine incursion into the Amazon Basin
10. Roger Kornberg to present lecture at the Joint Biophysical Society/IUPAB Meeting
11. Internationally recognized experts presents a complete overview on hydroecology and ecohydrology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015 To bolster its efforts ... HYPR Corp. announced today the addition of two new team ... as board advisor and David Raviv will act ... underscore HYPR Corp.,s commitment to providing the most secure solutions ... Sirota co-founded Layer 7 Technologies, a provider of security ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool specifically ... a healthier, happier life. That,s exactly what USANA,s ... do. The cutting-edge, portable health program provides a personalized ... to help improve your lifestyle and nutrition. ... and gala Wednesday night, USANA,s THA was honored with ...
(Date:6/24/2015)... 22, 2015 Research ... of the "Huawei Ascend Mate 7 Fingerprint ... their offering. Huawei,s technological choice for ... direction than Apple,s and Samsung,s one. The Ascend ... by Fingerprint Cards, a main actor in capacitive ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2
... Photosynthesis takes place in specialized membrane systems, made up ... A team of Ludwig-Maximilians-Universitaet (LMU) in Munich has now ... the edge of each stack. Scanning electron microscopy ... mays ) showing thylakoids (green) and assimilation starch granules ...
...  Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer ... products, has announced the issuance of two new U.S. ... of health data collected by point-of-care testing devices using ... a method and apparatus for manufacturing disposable dry test ...
... 2013 /PRNewswire-iReach/ -- Urologyweb.com, a leading website from Dr. ... outlining which prostate cancers really need treatment. ... favorable-risk Gleason 6 (3+3) prostate cancer and the ... not progress and do not need any treatment whether through ...
Cached Biology News:Photosynthesis: Membranes in tight corners 2PTS, Inc. Announces Two New Patents 2Which Prostate Cancers Really Need Treatment? 2Which Prostate Cancers Really Need Treatment? 3
(Date:7/24/2015)... Agritech Limited (NASDAQ GS: SEED) ("Origin", or the "Company"), a ... , today announced that the Company will report results for ... before the market opens on Wednesday, August 5th, 2015. ... 2015, at 9:00 a.m. ET / 9:00 p.m. ... in the call, please dial the following numbers approximately 5 ...
(Date:7/24/2015)... ... July 24, 2015 , ... ... to any modern scientific or pharmaceutical laboratory. FreezerPro® is an intuitive, fast, ... precisely where a sample is located even before opening the freezer door! ...
(Date:7/23/2015)... (PRWEB) , ... July 23, 2015 , ... Science and ... radiation, to new drug therapies and devices – according to Susan Chang, MD, director ... a session on how science and new technology are impacting the development of new ...
(Date:7/23/2015)... ... July 23, 2015 , ... July ... by providing more targeted treatment options with fewer side effects, according to Erik ... Anderson Cancer Center. , At the American Brain Tumor Association (ABTA) National Patient ...
Breaking Biology Technology:Origin Agritech Limited to Announce Third Quarter Fiscal 2015 Unaudited Financial Results on August 5th, 2015 2Origin Agritech Limited to Announce Third Quarter Fiscal 2015 Unaudited Financial Results on August 5th, 2015 3RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 2RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 3RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 4Experts Present How Science and New Technology are Driving New Brain Tumor Treatments and Improving Quality of Life 2Experts Present How Science and New Technology are Driving New Brain Tumor Treatments and Improving Quality of Life 3Radiation Oncology Advances Improve Safety and Efficacy of Treatment for Brain Tumors 2Radiation Oncology Advances Improve Safety and Efficacy of Treatment for Brain Tumors 3
... Signal Genetics, the parent company of Myeloma Health, ... oncology, today announced the formation of their Scientific Advisory ... Director, Jerome Lipper Multiple Myeloma Center, ... Medicine, Harvard Medical School Dr. Anderson of ...
... Calif., Oct. 26 Telik, Inc. (Nasdaq: ... company,s lead therapeutic product candidate, has been selected by ... Top 10 Most Interesting Oncology Projects to Watch."  Windhover ... executives in the pharmaceutical, biotechnology, and medical device industries. ...
... Regado Biosciences, a privately held company leading the development ... David J. Mazzo, PhD, President and CEO, will be ... Mazzo,s presentation will be given at the Waldorf-Astoria Hotel ... at 10:45 a.m. EDT in the Louis XVI Room. ...
Cached Biology Technology:Signal Genetics Announces Establishment of Scientific Advisory Board 2Signal Genetics Announces Establishment of Scientific Advisory Board 3TELINTRA® Named One of the 10 Most Interesting Oncology Projects to Watch 2TELINTRA® Named One of the 10 Most Interesting Oncology Projects to Watch 3Regado Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference in New York City 2Regado Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference in New York City 3
Sphingosine 1-phosphate receptor Edg-1...
Bag-1 (K-20)...
... atoms at the 3, 3', 4, and ... as an internal standard for the quantification ... LC-mass spectrometry. PGE2 is one of the ... one of the most widely investigated prostaglandins. ...
, Glycerol 30%...
Biology Products: